These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8952320)

  • 1. [A case of systemic sclerosis associated with interstitial pneumonia with various autoantibodies: improvement by intravenous cyclophosphamide therapy].
    Ishiyama K; Suwa A; Ohta S; Moriguchi M; Suzuki T; Miyachi K; Hara M; Kashiwazaki S
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Oct; 19(5):512-8. PubMed ID: 8952320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment with cyclosporine in a case of progressive interstitial pneumonia associated with systemic sclerosis].
    Fujisawa T; Yagi T; Kobayashi J; Suganuma H; Saito T; Takashima Y; Nakamura Y; Suda T; Chida K; Nakamura H
    Nihon Kokyuki Gakkai Zasshi; 2003 Jul; 41(7):480-5. PubMed ID: 12931677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases.
    Takahashi T; Asano Y; Amiya E; Hatano M; Tamaki Z; Ozeki A; Watanabe A; Kawarasaki S; Nakao T; Taniguchi T; Ichimura Y; Toyama T; Watanabe M; Hirata Y; Nagai R; Sato S
    Mod Rheumatol; 2012 Aug; 22(4):598-601. PubMed ID: 22015621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up.
    Tochimoto A; Kawaguchi Y; Hara M; Tateishi M; Fukasawa C; Takagi K; Nishimagi E; Ota Y; Katsumata Y; Gono T; Tanaka E; Yamanaka H
    Mod Rheumatol; 2011 Jun; 21(3):296-301. PubMed ID: 21240620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
    Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
    Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
    Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are high doses of prednisone necessary for treatment of interstitial lung disease in systemic sclerosis?
    Pérez Campos D; Estévez Del Toro M; Peña Casanovas A; González Rojas PP; Morales Sánchez L; Gutiérrez Rojas AR
    Reumatol Clin; 2012; 8(2):58-62. PubMed ID: 22317852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of interstitial pneumonia associated with dermatomyositis effectively treated with cyclosporin-A and cyclophosphamide pulse].
    Kotani T; Makino S; Kawasaki Y; Hirano S; Tabushi Y; Kagitani M; Takeuchi T; Hanafusa T
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):148-53. PubMed ID: 15997178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis.
    Vallance DK; Lynch JP; McCune WJ
    Curr Opin Rheumatol; 1995 May; 7(3):174-82. PubMed ID: 7612408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study.
    Sumida H; Asano Y; Tamaki Z; Aozasa N; Taniguchi T; Toyama T; Takahashi T; Ichimura Y; Noda S; Akamata K; Saigusa R; Miyazaki M; Kuwano Y; Yanaba K; Yoshizaki A; Sato S
    J Dermatol; 2018 Dec; 45(12):1425-1433. PubMed ID: 30289572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
    Tashkin DP; Roth MD; Clements PJ; Furst DE; Khanna D; Kleerup EC; Goldin J; Arriola E; Volkmann ER; Kafaja S; Silver R; Steen V; Strange C; Wise R; Wigley F; Mayes M; Riley DJ; Hussain S; Assassi S; Hsu VM; Patel B; Phillips K; Martinez F; Golden J; Connolly MK; Varga J; Dematte J; Hinchcliff ME; Fischer A; Swigris J; Meehan R; Theodore A; Simms R; Volkov S; Schraufnagel DE; Scholand MB; Frech T; Molitor JA; Highland K; Read CA; Fritzler MJ; Kim GHJ; Tseng CH; Elashoff RM;
    Lancet Respir Med; 2016 Sep; 4(9):708-719. PubMed ID: 27469583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.
    Yiannopoulos G; Pastromas V; Antonopoulos I; Katsiberis G; Kalliolias G; Liossis SN; Andonopoulos AP
    Rheumatol Int; 2007 Feb; 27(4):357-61. PubMed ID: 17021713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of intravenous cyclophosphamide pulse therapy for interstitial lung disease in a patient with systemic sclerosis on hemodialysis.
    Takahashi T; Asano Y; Sunaga R; Ichimura Y; Taniguchi T; Yamamoto M; Tamaki Z; Takekoshi T; Mitsui H; Sugaya M; Ohse T; Sato S
    J Dermatol; 2014 Jun; 41(6):533-5. PubMed ID: 24814462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of diffuse alveolar hemorrhage associated with interstitial pneumonia and systemic sclerosis].
    Toyoshima M; Chida K; Enomoto N; Nakamura Y; Imokawa S; Suda T
    Nihon Kokyuki Gakkai Zasshi; 2005 Jul; 43(7):437-41. PubMed ID: 16050472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SLE with interstitial pneumonia during cyclophosphamide pulse therapy].
    Kawamoto S; Kuroda H; Saito M; Azuma Y; Masuoka S; Watanabe S; Ikeda M; Yano H; Kobayashi M
    Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):638-43. PubMed ID: 9805918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An autopsied case of progressive systemic sclerosis with anti Wa antibody who showed a rapid progression].
    Abe T; Yachi A; Ishii Y; Takeshima Y; Yonezawa K; Ishibashi F; Tosaka M; Tanifuji J; Yoshida Y; Takano S
    Ryumachi; 1992 Oct; 32(5):488-94. PubMed ID: 1440086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?
    Abignano G; Bissell LA; Emery P; Del Galdo F; Buch MH
    Rheumatology (Oxford); 2016 Dec; 55(12):2273-2275. PubMed ID: 27744357
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of rapidly progressive interstitial pneumonia with anti-pL-12-antibodies successfully treated by pulse methylprednisolone and cyclophosphamide].
    Yahaba M; Suda A; Syoji R; Jujo T; Shinozaki T
    Nihon Kokyuki Gakkai Zasshi; 2008 Jul; 46(7):547-51. PubMed ID: 18700573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
    Bérezné A; Valeyre D; Ranque B; Guillevin L; Mouthon L
    Ann N Y Acad Sci; 2007 Sep; 1110():271-84. PubMed ID: 17911442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interstitial pneumonia treated with intermittent cyclophosphamide pulse therapy].
    Harada T; Takayama K; Kimotsuki K; Hidaka K; Miyazaki H; Kuwano K; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Nov; 34(11):1221-6. PubMed ID: 8976077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.